Objective: The European System for Cardiac Operative Risk Evaluation (EuroSCORE) calculator performance in 30-day outcome prediction after isolated aortic valve replacement (AVR) was evaluated to assess its absolute reliability and usefulness as selection criteria to percutaneous aortic valve implantation (PAVI). Methods: We carried out a retrospective statistical analysis on 379 patients (group 0) consecutively submitted to isolated AVR in the past 10 years of surgical activity. We discriminated two periods of 5 years each, so we considered two subgroups of patients: group 1 (200 patients operated during 1999-2003); group 2 (179 patients operated during [2004][2005][2006][2007][2008]. We used receiver operating characteristics (ROC) curves for discriminatory power analysis. Model calibration was evaluated with the Hosmer-Lemeshow goodness-of-fit test and Pseudo R 2 analysis. Results: The overall expected mortality rate at the logistic calculator was 9.37% compared with an observed 10-year mortality of 5.2% (p = 0.006). Absolute risk prediction in group 1 fitted the observed outcome ( p = 0.24) while expected mortality in group 2 was significantly higher than observed ( p = 0.005). Applying threshold values used as PAVI selection criteria (logistic EuroSCORE >20 or >15), against 29% and 24.3% expected mortality rate, respectively, we registered a significant difference in the observed values (11.4%, p = 0.022; 8.6%, p = 0.005, respectively). The Hosmer-Lemeshow test demonstrated a lack of model fit in the overall group ( p = 0.019). ROC analysis revealed a sufficient discriminatory power for either total population (logistic area under curve (AUROC) 0.706; 95% confidence interval (CI): 0.604-0.809; p = 0.002) and group 1 (logistic AUROC 0.752; 95% CI: 0.643-0.860; p = 0.002). Group 2 showed a lack of risk stratification (logistic AUROC 0.613; 95% CI: 0.401-0.824; p = 0.348). Conclusions: EuroSCORE appears to be an invalid model in absolute and relative risk prediction for isolated AVR. On this basis, its use in selecting candidates to PAVI should be carefully weighted. Correct stratification and sufficient calibration of absolute risk estimate of high-risk patients are, therefore, mandatory in the aim of assigning those patients who show risk factors really responsible for the worst surgical outcome to new techniques. The goal should be reached by exploring the weight of each independent predictor of death in each single institution involved in PAVI procedures, evaluating local surgical results in terms of absolute risk and analysing those variables significantly affecting relative risk. #
Introduction
The need for a reliable risk stratification system has been recognised worldwide with the aim of assessing and comparing results among different institutions after cardiac surgery operations. The usefulness of an ideal predictive scoring system should be validated, taking in account two main concepts: absolute risk (AR) as risk of occurrence of an event over a time period, and relative risk (RR) as risk of occurrence of an event with and without the influence of a particular factor. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a prognostic scoring model introduced in 1999 for patients undergoing cardiac surgery in Europe [1] . Worldwide, it is used almost everyday in each cardiac surgery unit for surgical risk stratification in any cardiac operation. It has been widely proposed either as a useful tool for the assessment of absolute and relative risk in aortic valve replacement (AVR) or for comparing surgical outcomes of different institutions or surgical techniques. Recently, it was considered one of the main criteria on the basis of selection of candidates to percutaneous aortic valve implantation (PAVI) procedures as reported in literature [2, 3] . The aim of this article is to validate EuroSCORE absolute and relative risk model in 30-day outcome prediction after isolated AVR and to validate it as selection criteria to PAVI procedures. Furthermore, looking at the prospective risk assessment of patients undergoing AVR, we carried out an original evaluation with regard to the chance to correctly reclassify those patients considered eligible for PAVI techniques, according to the logistic EuroSCORE risk stratification. The study is based on the analysis across 10 years of experience in a single institution.
Materials and methods
From 1 January 1999 to 31 December 2008, 379 consecutive patients (group 0) underwent isolated AVR for aortic valve stenosis at the Department of Cardiac Surgery of University G.D'Annunzio, Chieti, Italy. This retrospective analysis was performed by collection of patients' clinical files and post hoc calculation of 30-day expected risk of death using both EuroSCORE calculators, both additive and logistic, for each patient. The study population was divided into two subgroups of 5 consecutive years each to evaluate possible differences of prediction models with respect to the era of surgery: patients operated between 1 January 1999 and 31 December 2003 were considered as group 1; patients operated between 1 January 2004 and 31 December 2008 entered group 2. Follow-up was 100% complete and was obtained using the hospital diagnosis-related groups (DRGs) recordings cross-matched with patients' clinical files and telephone inquiries. Concerning the limited number of patients operated upon during the pre-EuroSCORE era, we considered the same variables included in this calculator using same cut-off limits in a post hoc analysis.
Statistical analysis
Categorical variables were expressed as frequencies and percentage. Continuous variables were checked for normal distribution with visual inspection of bar graphs, histograms and the Shapiro-Wilk test. Normal distribution was described as mean, standard deviation (SD) or 95% confidence interval (CI), whereas not-normal distribution was expressed as median (25th-75th percentiles). Categorical variables were analysed by the chi-square test and the Fisher's exact test for cell frequencies equal to or less than five. Normal continuous variables were analysed using unpaired t-test, while for not normally distributed data the Mann-Whitney test was used. We tested differences between observed and expected frequencies with chi-square goodness-of-fit. Odds ratio (OR) for univariate analysis of independent predictors was calculated using logistic regression analysis. Performance of EuroSCORE model was assessed by receiver operating characteristics (ROC) curves and analysis of the area under curve (AUROC) for discriminatory power. The calibration model was evaluated using the Hosmer-Lemeshow goodnessof-fit test, when applicable, and Pseudo R 2 according to the Cox and Snell's and the Nagelkerke's tests. Significance level for all tests was set to 5%. Data were analysed using SPSS ver. 16.01 for Windows and R Software for Statistical Computing ver. 2.80 (R Development Core Team, Vienna, Austria).
Results
Patient population preoperative data are reported in Table 1 . Concerning clinical presentation, dyspnoea and poor left ventricular (LV) function were more prevalent in group 1 and diabetes, hypertension and female gender were more significant in group 2. In Table 2 , perioperative data are summarised. It is noticeable that a different distribution of two types of myocardial protection was used across the observed time span. Intermittent antegrade warm blood cardioplegia, according to the protocol proposed by Calafiore et al. [4] , is the only one used up to October 2004; from then on, it was replaced by histidine-tryptophan-ketoglutarate (HTK) solution (Custodiol, Koehler Chemie, Alsbach-Haenlein, Germany). When the cardioplegia protocol entered univariate analysis as an independent predictor of death, association with mortality accounted for an OR of 2.22 (CI 0.72-6.84, p = 0.16). The lack of statistical significance is probably justified by a low power of analysis due to a small sample size of the patient population. Table 3 shows predictive variables of 30-day mortality at univariate analysis; among these, emergency operation (OR = 5.6, 95% CI = 1.1-28, p = 0.03) and chronic renal failure (OR = 3.7, 95% CI = 1.15-12, p = 0.02) were statistically significant.
Absolute risk and risk stratification
The expected mortality in group 0 from the additive and logistic EuroSCORE was 6.98% (n = 26.4/379, 95% CI 6.7-7.2%) and 9.37% (n = 35.5/379, 95% CI 8.6-10.2), respectively, compared with an observed mortality rate of 5.2% (n = 20/379) (additive expected vs observed p = 0.19; logistic expected vs observed p = 0.006). Absolute risk prediction in group 1 fitted the observed outcome: expected additive, expected logistic and observed mortality were 6.83% (n = 12.8/200, 95% CI 6.4-7.2), 9.40% (n = 0.18.8/200, 95% CI 8.1-10.6) and 7% (n = 14/200), respectively ( p > 0.05). In group 2, an overestimation of the mortality rate using both calculator systems was noticed: expected additive mortality was 7.14% (n = 0.12.8/179, 95% CI 6.8-7.5), expected logistic mortality was 9.34% (n = 16.7/179, 95% CI 8.3-10.4) compared with an observed mortality rate of 3.3% (n = 6/179) (additive expected vs observed p = 0.048; logistic expected vs observed p = 0.005). These differences, along with observed/expected (O/E) ratio, are represented in Fig. 1 ; it has to be noted that expected mortality calculated with both methods in each group do not differ statistically (additive and logistic expected p > 0.05) while observed mortality rate between groups appears to be borderline with regard to the statistical point of view ( p = 0.07). If threshold values used as PAVI selection criteria are applied (logistic EuroSCORE >20 and recently logistic EuroSCORE >15) we compare an observed mortality of 11.4% (n = 4/35) and 8.6% (n. = 5/58), respectively, to an expected mortality rate of 29% (n = 10.1/35, 95% CI 25.8-32.1) and 24.3% (n = 14.1/58, 95% CI 21.8-26.7), respectively. In both groups, mortality was strongly overestimated by a statistical point of view (logistic EuroSCORE threshold >20, p = 0.022; logistic Euro-SCORE threshold >15, p = 0.005) with an O/E of 0.40 and 0.35, respectively. Calibration analysis performed on group 0 by the Hosmer-Lemeshow goodness-of-fit test demonstrated a lack of fit between observed and predicted death rate by EuroSCORE logistic model (chi-square 18.35, df = 8, p = 0.019). Pseudo R 2 analysis showed also some usefulness of the explanatory variable in predicting the response variable (outcome) with a Cox and Snell's Pseudo R 2 and (Fig. 3) . In group 2, a lack of difference between the reference line representing the null hypothesis (0.5) compared with additive AUROC (0.592, 95% CI 0.385-0.799, p = 0.444) and logistic AUROC (0.613, 95% CI 0.401-0.824, p = 0.348) was observed (Fig. 4) .
Discussion
The rationale for the use of a scoring system for preoperative risk assessment is to evaluate the effective outcome of a treatment expressing a real benefit for the patient. The evaluation of a surgical treatment should be based on the outcome analysis either per se or in presence of additional risk factors. The risk of a given outcome under different conditions can be compared in several ways and expressed in terms of relative or absolute risk. EuroSCORE system considers some independent variables in a multivariate logistic model. System validation is mandatory and general limitations for its application concern the use of comparable demographics and ethnic characteristics, same preoperative risk factors and comparable treatment options with respect to the original dataset [5, 6] . A true limitation to using the EuroSCORE system in isolated AVR is its original validation on a mixed patients' population in which coronary artery bypass grafting procedures were prevalent and isolated AVR was poorly represented [5] . This could be the reason that several independent variables, possibly acting as outcome predictors of aortic valve surgery, are ignored or inadequately considered in the EuroSCORE calculator [7] . There is some evidence in the literature of the incorrect prediction of AVR outcome using the Euro-SCORE model; Grossi et al. recently demonstrated in a cohort of high-risk AVR (EuroSCORE 7) that logistic EuroSCORE greatly overpredicts mortality in terms of absolute event rate [8] . Other reports demonstrated that additive and logistic EuroSCORE failed to predict mortality to open-heart surgery in octogenarian candidates, a subset of patients frequently observed in daily practice [9] [10] [11] . Osswald et al. report on the real risk of overestimation of death by EuroSCORE for patients undergoing isolated AVR, enlightening a possible incorrect assignment of high-risk patients to PAVI procedures [12] . Similarly to the abovementioned studies, our results demonstrate an overall incorrect prediction of death rate with overestimation of absolute risk and a model calibration with a not-significant level of goodness-of-fit. The AUROC discriminatory power of ROC analysis shows progressive decrease of performance across the observed time span with the major clinical evidence being a reduced predictive discriminatory power of EuroSCORE in the past 5 years. A possible explanation of reduced performance and evidence of the gap between observed mortality rates across the two subgroups depicted in Fig. 1 could be referred to a series of factors: improved anaesthesiological techniques, better intensive care treatment with fast-track protocols adoption and different protocols of myocardial protection, as it happened in our experience. In fact, the analysis of our patient population showed a high OR for death in case of blood cardioplegia compared with HTK solution use. Although it did not reach statistical significance, probably because of a not-yet sufficient sample size, its clinical impact is, however, important and needs to be further investigated. On the other hand, it is really difficult to assess the weight of other factors, possibly acting as independent variables, as they are mainly neither measurable nor constant over time. The univariate analysis of risk factors in our population shows specific statistical weights different from those depicted in the original model. The original sign on the basis of EuroSCORE and the overlapping agreement of statistical evidence coming from the analysis of single-centre reports [8, 12, 13] seems to be a strong evidence supporting the need for recalibration of this model for isolated AVR. It is highly important that patient selection to alternative treatments is based on a correct evaluation of absolute and relative risk for each treatment considered, surgical or interventional. A model of risk prediction validated for isolated AVR does not exist in the literature. It is therefore mandatory in our opinion that each centre involved in PAVI procedures at least carries out a retrospective evaluation of in-house surgical results considering absolute risk and analyses those variables that significantly affect relative risk. On the other hand, PAVI experience should be submitted to a univariate or multivariate analysis on those patients undoubtedly candidate to this alternative treatment so that absolute and relative risk reduction could be quantified. In this objective, a propensity score-matching analysis considering the weight of any single independent variable affecting real results should be preferable.
Even if the best theoretical approach to a risk evaluation is a local recalibration of a risk model using local univariate variables affecting patients' outcome, this is difficult to be obtained due to the high number of patients needed to reach a well-powered analysis. This is also a limitation of the present study.
One of the elements playing an important role in favour of the PAVI procedure is absolute risk reduction predicted using EuroSCORE model as a benchmark. This appears to be a convincing evidence that could be unmasked if the comparison of real results obtained with each technique were considered.
The trend to overestimation of absolute risk in AVR appears to be a recognised study limitation in several recently published PAVI reports [3, 14, 15] . However, the most important limitation not reported in PAVI literature is the lack of any consideration about patient relative risk stratification; this does not help to identify those patients who could potentially benefit from an alternative treatment.
It is moreover noticeable that the 20% expected risk according to logistic EuroSCORE is the proposed cut-off in case of standard sheath. Recent availability of smaller devices (18 F sheath) led interventional cardiologists to expand patients' selection lowering cut-off for expected risk to 15% logistic EuroSCORE. It is, in our opinion, mandatory to stress that on the basis of our results and what is published in literature, no sensitivity and specificity analysis exists that justifies the suggested cut-off choice.
The application of an invalidated model may generate an incorrect opinion about the potential benefits arising from the adoption of interventional procedures. If applied to daily practice, this concept leads either to an overestimation of advantages on mortality or to misunderstand outcome improvement coming from interesting alternatives to surgery. In conclusion, even if our analysis did not reach statistical significance for validating EuroSCORE as a major criterion of risk assessment in isolated AVR candidates, its weak predictive value may allow considering it as a minor criterion. This is equally true in case of new procedures that have to be evaluated as an alternative treatment in high-risk patients. 
